Evidence map›Paper›PMID 28754980›Full record

ArticleScientific reports2017

Regulation of Sema3c and the Interaction between Cardiac Neural Crest and Second Heart Field during Outflow Tract Development.

Kazuki Kodo, Shinsuke Shibata, Sachiko Miyagawa-Tomita, Sang-Ging Ong, Hiroshi Takahashi, Tsutomu Kume, Hideyuki Okano, Rumiko Matsuoka, Hiroyuki Yamagishi

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. An Outflow Tract Myocardium-Specific Enhancer at the Sema3c Locus During Heart Development.Genes to cells : devoted to molecular & cellular mechanisms · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. In-Depth Genomic Analysis: The New Challenge in Congenital Heart Disease.International journal of molecular sciences · 2024
    Review
  10. Article
  11. Human Genetics of Truncus Arteriosus.Advances in experimental medicine and biology · 2024
    Review
  12. Review
  13. Article
  14. Analysis of theTranslational pediatrics · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Genomic frontiers in congenital heart disease.Nature reviews. Cardiology · 2022
    Review
  20. Modeling Paracrine Noncanonical Wnt Signaling In Vitro.Journal of visualized experiments : JoVE · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Kazuki KodoDepartment of Pediatrics, Division of Pediatric Cardiology, Keio University School of Medicine, Tokyo, 160-8582, Japan. kazukikodo.a3@keio.jp.
Shinsuke ShibataDepartment of Physiology, Keio University School of Medicine, Tokyo, 160-8582, Japan.
Sachiko Miyagawa-TomitaDepartment of Pediatric Cardiology, Tokyo Women's Medical University, Tokyo, 162-8666, Japan.
Sang-Ging OngStanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, 94305-5111, USA.
Hiroshi TakahashiDepartment of Neurology, National Hospital Organization, Tottori Medical Center, Tottori, Tottori, 689-0203, Japan.
Tsutomu KumeFeinberg Cardiovascular Research Institute, Feinberg School of Medicine, Northwestern University, Chicago, IL, 60611, USA.
Hideyuki OkanoDepartment of Physiology, Keio University School of Medicine, Tokyo, 160-8582, Japan.
Rumiko MatsuokaDepartment of Pediatric Cardiology, Tokyo Women's Medical University, Tokyo, 162-8666, Japan.
Hiroyuki YamagishiDepartment of Pediatrics, Division of Pediatric Cardiology, Keio University School of Medicine, Tokyo, 160-8582, Japan. hyamag@keio.jp.
Keio University · JPTokyo Women's Medical University · JPNational Hospital Organization · JPNorthwestern University · USStanford University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The cardiac neural crest cells (cNCCs) and the second heart field (SHF) play key roles in development of the cardiac outflow tract (OFT) for establishment of completely separated pulmonary and systemic circulations in vertebrates. A neurovascular guiding factor, Semaphorin 3c (Sema3c), is required for the development of the OFT, however, its regulation of the interaction between cNCCs and SHF remains to be determined. Here, we show that a Sema3c is a candidate that mediates interaction between cNCCs and the SHF during development of the OFT. Foxc1/c2 directly activates the transcription of Sema3c in the OFT, whereas, a hypomorph of Tbx1, a key SHF transcription factor, resulted in the ectopic expression of Sema3c in the pharyngeal arch region. Fgf8, a downstream secreted factor of Tbx1, inhibited the expression of Sema3c in cNCCs via activation of ERK1/2 signaling. Blocking of FGF8 caused ectopic expression of SEMA3C and a migration defect of cNCCs, resulting in abnormal chick pharyngeal arch development. These results suggest that proper spatio-temporal expression of Sema3c, regulated positively by Foxc1/c2 and negatively by the Tbx1-Fgf8 cascade, respectively, is essential for the interaction between cNCCs and the SHF that correctly navigates cNCCs towards the OFT, composed of SHF-derived cells.

Indexed as

AnimalsBase SequenceCell MovementFibroblast Growth Factor 8Forkhead Transcription FactorsHeartMiceModels, BiologicalNeural CrestSemaphorinsSignal TransductionStem CellsT-Box Domain ProteinsFibroblast Growth Factor 8Forkhead Transcription FactorsFoxc1 protein, mousemesenchyme fork head 1 proteinsemaphorin 3C protein, mouseSemaphorinsT-Box Domain ProteinsTbx1 protein, mouse

Identifiers

PMID28754980
PMCPMC5533775
OpenAlexW2737180196

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.